SLC7A11 and neoplasm: Biologically, SLC7A11 knockdown promotes ALOX12’s lipoxygenase activity to increase the peroxidation of PUFA-containing phospholipids, ultimately inducing ferroptosis and thereby inhibiting tumor progression [30].